Engagement in drug treatment following nonfatal overdose among people who inject drugs in Appalachia-Reference-Cited by-同舟云学术

Engagement in drug treatment following nonfatal overdose among people who inject drugs in Appalachia

Published:2021-07 Issue: Volume:93 Page:103176
ISSN:0955-3959
Container-title:International Journal of Drug Policy
language:en
Short-container-title:International Journal of Drug Policy

Author:

Allen Sean T.,Wedlock Patrick T.,White Rebecca Hamilton,Schneider Kristin E.,O'Rourke Allison,Ahmad N. Jia,Weir Brian W.,Kilkenny Michael E.,Sherman Susan G.

Funder

Johns Hopkins University

National Institutes of Health

District of Columbia Developmental Center for AIDS Research

Publisher

Elsevier BV

Subject

Health Policy,Medicine (miscellaneous)

Reference40 articles.

1. Non-prescribed buprenorphine in New York City: Motivations for use, practices of diversion, and experiences of stigma;Allen;Journal of Substance Abuse Treatment,2016

2. Understanding the public health consequences of suspending a rural syringe services program: A qualitative study of the experiences of people who inject drugs;Allen;Harm Reduction Journal,2019

3. Estimating the number of people who inject drugs in a rural county in Appalachia;Allen;American Journal of Public Health,2019

4. Overcoming barriers to prescribing buprenorphine for the treatment of opioid use disorder: recommendations from rural physicians;Andrilla;The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association,2019

5. Geographic Distribution of providers with a DEA waiver to prescribe buprenorphine for the treatment of opioid use disorder: A 5-year update;Andrilla;The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association,2019

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Opioid Overdoses and Take-Home Naloxone Interventions: Ethnographic Evidence for Individual-Level Barriers to Treatment of Opioid Use Disorders in Rural Appalachia;Substance Use & Misuse;2024-04-18

2. Pronounced State-Level Disparities in Medicaid Prescribing of Buprenorphine for Opioid Use Disorder (2019–2020);Journal of Studies on Alcohol and Drugs;2024-01

3. Buprenorphine After Nonfatal Opioid Overdose: Reduced Mortality Risk in Medicare Disability Beneficiaries;American Journal of Preventive Medicine;2023-07

4. Adverse drug effects as a deterrent against willingness to use in the future among nightclub/festival attendees;Drug and Alcohol Review;2023-04-26

5. Pronounced State Level Disparities in Medicaid Prescribing of Buprenorphine for Opioid Use Disorder (2019-2020);2022-09-29